Located at Azuqueca de Henares`s manufacturing facility (Liconsa), this dedicated R&D center is engaged in scientific research and development activities, specialized in oral drug delivery formulations and inhalation drug delivery formulations, for a wide range of therapeutic areas (Cardiovascular, Gastroenterology, Anti infectives, Central Nervous System and Respiratory).
Laboratorios Liconsa has developed a new treatment for respiratory tract diseases by propellant-free nebulization, with the financial support from the CDTI and the European Union through FEDER funds.
This project has been executed in its facilities located in Azuqueca de Henares, as planned it was finished in April 2020 and had a financed budget of € 1,118,680.
ERDF: European Regional Development Fund. A way to build Europe.
Laboratorios Liconsa is currently developing NEW INHALATION PRODUCTS FOR THE UNITED STATES MARKET, aimed at treating asthma and COPD.
This project is funded by the Industrial Technological Development Center (CDTI) and the European Union through Technological Fund.
We invest in your future.